Market Insight Proteins, Antibodies & ADCs

Panel Discussion: Mastering Stability & Characterisation: Building Confidence In Protein & Antibody Therapeutics From Bench To Batch

Christian Hunzinger

Senior Director CMC Development Proteins, ADCs, & Clinical Entities

BioNTech

Fabio Centola

CQA Manager

Merck KGaA

Dennis Ungan

Principal Scientist

Novartis

15 July, 2026

Watch time: 26 Minutes

Highlights

Takeaways

•Ensuring product stability across the lifecycle
•Making complex methods scalable, transferable & regulatory-ready
•Identification of critical attributes for stability & characterisation

Moderator: Fabio Centola, CQA Manager, Merck KGaA

Panellists:
Dennis Ungan, Principal Scientist, Novartis
Christian Hunzinger, Senior Director CMC Development Proteins, ADCs, & Clinical Entities, BioNTech

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.

Upgrade

Full Video Transcript